about
Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.MHC class I multimersProlonged activation of virus-specific CD8+T cells after acute B19 infection.HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic RatsLoss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27–restricted human immune responseAnalysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing propertiesCrystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimmingInteraction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.Data showing non-conventional HLA-B27 expression in axial joints and gut tissue from B27 transgenic rats, and in frozen and paraffin-fixed synovial SpA tissue.Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humansDiscovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.HLA B27 in health and disease: a double-edged sword?Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis.HLA-B27.Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.Two birds with one stone: doing metabolomics with your proteomics kit.The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis.High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitopeHLA-B27 and disease pathogenesis: new structural and functional insights.Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patientsParvovirus 4 infection and clinical outcome in high-risk populations.CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responsesAnti-tumour necrosis factor therapy in seronegative spondyloarthritis.The phenotype of circulating follicular-helper T cells in patients with rheumatoid arthritis defines CD200 as a potential therapeutic target.A method for producing monoclonal antibodies to human T-cell-receptor beta-chain variable regions.Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis.Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitisThe genetic association of RUNX3 with ankylosing spondylitis can be explained by allele-specific effects on IRF4 recruitment that alter gene expression.The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation.The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis.The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment.Polymorphisms in the F Pocket of HLA-B27 Subtypes Strongly Affect Assembly, Chaperone Interactions, and Heavy-Chain Misfolding.
P50
Q24798335-2C2DF57E-A36A-4141-9791-9B8A6FDF055CQ24805668-1C955E1C-DEC1-4CF2-AC7E-9E247DED302EQ24811737-3B9B533A-C825-4FBE-9E87-4FD6CE1A6C3EQ27303777-C3B1A0E2-1596-4079-8B04-4AB58124EFDEQ27487784-0B40E621-4424-4EC1-82E2-2B9CC43BE061Q27491282-9EE5EBF8-03C8-4394-A44D-22EAE635204BQ27667505-CE1B08A4-F0C9-40A2-8C0B-B191A108BDB4Q29417082-88807502-AE22-47DC-948D-B992CB380183Q31131617-3034C269-6571-4ACC-A2EB-74C84CA041C2Q33987526-82EA0378-726B-4131-99C2-E1F7FC7CB814Q34047987-1F1361F7-26B2-4409-AE52-85AAFCA9B8D6Q34142454-5DA91D18-9101-4462-B2D2-D434A509225FQ34265730-BBB627BF-028E-48FC-9C8C-26387FD237B5Q34471169-0B5D3004-BC8F-4117-BB87-7C4B87F9A349Q34499385-DE154E59-DD52-4BDC-99B6-D51741270E70Q34647872-4048D085-7B22-4F41-94AF-905541BD8F64Q34693456-BE3E38FD-DEE5-47A6-A124-88380285976BQ34710978-195C6175-70B4-41CA-9EE6-21C7EBB8B2B8Q34833986-87DD6CA2-2C19-4B08-91F4-A3A2F1957546Q35139637-EADF55B7-3663-4D19-A372-999BBA109CC8Q35404598-EF6DC27F-2893-454C-9505-6F4751FE3160Q35571032-1E841CF6-E2F7-4235-B069-C52876EE3DCBQ35645174-0F865074-1800-4310-81EC-31C3F72C29EDQ35751704-C89FAEC7-6579-4B5D-9930-A4223512480CQ35842117-9799194D-56BE-4D57-82BF-0FFA0FF1172EQ35975989-0F23FCFD-431E-4F84-BB79-09B92213930AQ36008355-115AD253-4531-43AC-9612-B8F7A39D8050Q36190907-29A8E49E-970D-4CD2-9B3C-500E4DBD8AF0Q36317934-4C8B47CE-5CF3-417C-87BF-926A099FC567Q36655171-38460EB4-D624-4E5B-9304-D94A007CC39CQ36859633-413E40D4-03DA-434D-8003-0E7113918865Q36866358-15808E21-BF22-4ECE-A154-EDBA539E0643Q36913820-88C1D7C2-FE51-4EBE-8004-16075F87CD24Q37076771-232BA87C-2408-4257-AA6D-920690D16CE5Q37156403-05996BC6-EAF9-4218-8407-66519194CA4AQ37234677-1A7491C3-5094-4E76-9841-FAC40908D02BQ37471686-E6A76A5E-BE52-4E7F-B155-B7638E045D53Q37592176-0D4922F8-1C12-4A8E-8073-C9C840F9275BQ38529525-149B2E8E-AA2A-497F-8A7D-F2690CF94D02Q38741792-B13AF188-C357-4BC0-A352-16E1CF8E66E2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paul Bowness
@ast
Paul Bowness
@en
Paul Bowness
@es
Paul Bowness
@nl
type
label
Paul Bowness
@ast
Paul Bowness
@en
Paul Bowness
@es
Paul Bowness
@nl
altLabel
paul bowness
@en
prefLabel
Paul Bowness
@ast
Paul Bowness
@en
Paul Bowness
@es
Paul Bowness
@nl
P106
P31
P496
0000-0003-4597-0484